| 10815283 |
Peptides for treatment of diabetes |
Jan Alenfall, Pontus Dunér, Anna NILSSON |
2020-10-27 |
| 9169315 |
Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity |
Martina Kalle, Gopinath Kasetty, Nils Martin Malmsten, Praveen Papareddy, Artur Schmidtchen |
2015-10-27 |
| 9163072 |
Mutants of interleukin-1 receptor antagonist |
Eva Dahlen, Karin Elisabeth Brachan, Patrick Thomas Höjman, Cecilia Ann-Christin Malmborg Hanger, Marie Asa Ingegerd Karlsson +1 more |
2015-10-20 |
| 9132165 |
Synthetic peptides and their use |
Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Bo Svenson |
2015-09-15 |
| 8846608 |
Human lactoferrin derived peptides and their use |
Margit Mahlapuu, Camilla Björn, Veronika Sjöstrand, Bo Svenson |
2014-09-30 |
| 8735353 |
Polypeptides and uses thereof |
Martina Kalle, Gopinath Kasetty, Nils Martin Malmsten, Praveen Papareddy, Artur Schmidtchen |
2014-05-27 |
| 8552149 |
Polypeptides and use thereof |
Christina Furebring, Anna Rosén, Karin Haraldsson, Erika Gustafsson |
2013-10-08 |
| 8303945 |
Mutants of interleukin-1 receptor antagonist |
Eva Dahlen, Karin Elisabeth Barchan, Patrick Thomas Höjman, Cecilia Ann-Christin Malmborg Hager, Marie Asa Ingegerd Karlsson +1 more |
2012-11-06 |
| 8076286 |
Antimicrobial peptides and use thereof |
Artur Schmidtchen, Martin Malmsten |
2011-12-13 |
| 7615225 |
Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen |
Goran Forsberg, Eva Erlandsson, Per Antonsson |
2009-11-10 |
| 7125554 |
Engineered superantigen for human therapy |
Goran Forsberg, Eva Erlandsson, Per Antonsson |
2006-10-24 |